banner2

Getting started
Cyclopropylmagnesium Bromide CAS 23719-80-4

Cyclopropylmagnesium Bromide CAS 23719-80-4 - Factory, Suppliers, Manufacturers from China

Cyclopropylmagnesium Bromide CAS 23719-80-4, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Darifenacin Hydrobromide Darifenacin HBr CAS 133099-07-7 Assay ≥99.0% API Factory High Quality
Read More

Teneligliptin Hydrobromide Teneligliptin HBr CAS 906093-29-6 CAS 906093-29-6 Purity >99.5% (HPLC) DPP-4 Inhibitor Factory

4-(Carboxybutyl)triphenylphosphonium Bromide CAS 17814-85-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4-(Carboxybutyl)triphenylphosphonium Bromide CAS 17814-85-6 Purity >98.0% (HPLC)

Tetrahydrofurfuryl Bromide CAS 1192-30-9 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Tetrahydrofurfuryl Bromide CAS 1192-30-9 Purity >98.0% (GC)

2-(Fmoc-Amino)ethyl Bromide CAS 340187-12-4 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 2-(Fmoc-Amino)ethyl Bromide CAS 340187-12-4 Purity >98.0% (HPLC)

3-Chlorophenethyl Bromide CAS 16799-05-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 3-Chlorophenethyl Bromide CAS 16799-05-6 Purity ≥97.0% (GC)

Propionyl Bromide CAS 598-22-1 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Propionyl Bromide CAS 598-22-1 Purity ≥98.0% (GC)

banner1

Top Selling Products

Related Blog
Reviews

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) -Shanghai Ruifu Chemical Co., Ltd. will attend with customers.

Shanghai Ruifu Chemical Co., Ltd. will attend the The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) with customers. The 87th China International ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...

2022.09.25 23:12:20
2022.09.02 20:50:06
2022.08.26 00:32:15
2022.05.19 01:24:37
2022.01.08 10:25:08
2021.12.14 19:03:06

related search